Cargando…
Ameliorating inflammation in an in vitro model by screening the anti-inflammatory and immunomodulatory roles of putative probiotics in inflammatory bowel disease
IBD is considered a relapsing disease with relapsing phases. Probiotics are beneficial microorganisms that modulate inflammatory signaling pathways. Our aim was to identify the precise molecular effects of probiotics on inflammatory signaling pathways during the presence of inflammation. Evaluation...
Autores principales: | Aghamohammad, Shadi, Sepehr, Amin, Miri, Seyedeh Tina, Najafi, Saeideh, Pourshafie, Mohammad R., Rohani, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558596/ https://www.ncbi.nlm.nih.gov/pubmed/37809831 http://dx.doi.org/10.1016/j.heliyon.2023.e19475 |
Ejemplares similares
-
The Role of Combining Probiotics in Preventing and Controlling Inflammation: A Focus on the Anti-Inflammatory and Immunomodulatory Effects of Probiotics in an In Vitro Model of IBD
por: Aghamohammad, Shadi, et al.
Publicado: (2022) -
Anti‐inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control
por: Aghamohammad, Shadi, et al.
Publicado: (2022) -
Investigation of the anti-inflammatory effects of native potential probiotics as supplementary therapeutic agents in an in-vitro model of inflammation
por: Aghamohammad, Shadi, et al.
Publicado: (2023) -
The effects of the probiotic cocktail on modulation of the NF-kB and JAK/STAT signaling pathways involved in the inflammatory response in bowel disease model
por: Aghamohammad, Shadi, et al.
Publicado: (2022) -
Dynamic Population of Gut Microbiota as an Indicator of Inflammatory Bowel Disease
por: Salimi, Afsaneh, et al.
Publicado: (2022)